Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy.

Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy.

[Anonymous].  2011.  Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: an ACUITY trial substudy.. Journal of thrombosis and thrombolysis. 31(2):139-45.

Oral antiplatelet therapy for acute coronary syndromes: aspirin, P2Y12 inhibition and thrombin receptor antagonists.

Oral fluids that detect cardiovascular disease biomarkers.

Salivary biomarkers associated with myocardial necrosis: results from an alcohol septal ablation model.

Increased mortality among patients taking digoxin--analysis from the AFFIRM study.

Atomoxetine does not alter cocaine use in cocaine dependent individuals: double blind randomized trial.

Fibrinolytic therapy versus primary percutaneous coronary interventions for ST-segment elevation myocardial infarction in Kentucky: time to establish systems of care?

Fibrinolytic therapy versus primary percutaneous coronary interventions for ST-segment elevation myocardial infarction in Kentucky: time to establish systems of care?

[Anonymous].  2013.  Fibrinolytic therapy versus primary percutaneous coronary interventions for ST-segment elevation myocardial infarction in Kentucky: time to establish systems of care? Southern medical journal. 106(7):391-8.

Acute myocardial injury from carbon monoxide poisoning by cardiac magnetic resonance imaging.

Value of high-sensitivity troponin in assessing the extent of benefit provided by ticagrelor versus clopidogrel in non-ST-segment elevation acute coronary syndromes.

Value of high-sensitivity troponin in assessing the extent of benefit provided by ticagrelor versus clopidogrel in non-ST-segment elevation acute coronary syndromes.

[Anonymous].  2014.  Value of high-sensitivity troponin in assessing the extent of benefit provided by ticagrelor versus clopidogrel in non-ST-segment elevation acute coronary syndromes.. Circulation. 129(3):278-80.

QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.

QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.

[Anonymous].  2014.  QRS duration predicts death and hospitalization among patients with atrial fibrillation irrespective of heart failure: evidence from the AFFIRM study.. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 16(6):803-11.